Laurus Labs Hits New 52-Week High at Rs. 996.95

Laurus Labs has reached a significant milestone by hitting a new 52-week high of Rs.996.95 today, November 10, 2025. This achievement underscores the stock's robust performance, particularly in the context of the pharmaceuticals and biotechnology sector. Over the past year, Laurus Labs has demonstrated impressive growth, with a remarkable 97.96% increase in its stock price, significantly outperforming the Sensex, which has risen by just 5.17% during the same period. The stock has shown consistent upward momentum, gaining 0.93% over the last two days. Notably, Laurus Labs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong market position. The company's financial health is reflected in its substantial net profit growth of 993.4% reported in September, alongside a 28.12% increase in net sales over the past nine months. With high institutional holdings at 37.63%, Laurus Labs continues to attract attention in the market, showcasing its ability to generate significant returns and maintain a competitive edge in the industry.